The oncogenetic role of mTORC2 has been recently highlighted by an investigation that documented the importance of mTORC2 in the development and progression of prostate cancers induced in mice by phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss [58]. Here, PTEN is linked to prostate carcinoma.